ROMARK GLOBAL PHARMA, LLC

Lobbying Spend

—

Filings

Firms Hired

Active Period

2022–2024

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2024	—	2	1
2023	—	6	1
2022	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BROWNSTEIN HYATT FARBER SCHRECK, LLP	—	10

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	7
SENATE	7

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	8

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2617117th Congress

Consolidated Appropriations Act, 2023

Cited source text and reported amounts

Issues regarding Biomedical Advanced Research and Development Authority H.R. 2617, Consolidated Appropriations Act, 2023

Client expense: — · Firm income: $20,000

Matched citations: H.R. 2617

ROMARK GLOBAL PHARMA, LLC — Lobbying Disclosure | Poliscope